METASTATIC NASOPHARYNGEAL CARCINOMA
Clinical trials for METASTATIC NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study tests a combination of three drugs—an EGFR antibody, a PD-1 inhibitor, and chemotherapy—in people whose nasopharyngeal cancer has come back or spread. The goal is to see if this mix can shrink tumors or delay growth better than current options. About 148 adults aged 18…
Matched conditions: METASTATIC NASOPHARYNGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Double immunotherapy may stall return of rare nasal cancer
Disease control Recruiting nowThis study is for people with a type of nose and throat cancer (nasopharyngeal carcinoma) that has come back or spread. After initial treatment with chemotherapy and the immunotherapy drug nivolumab, participants will receive either nivolumab alone or nivolumab plus another drug …
Matched conditions: METASTATIC NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:59 UTC
-
New hope for Hard-to-Treat nasopharyngeal cancer: drug combo trial launches
Disease control Recruiting nowThis study is for people with advanced nasopharyngeal cancer that has returned or spread and no longer responds to standard treatments. It tests whether adding a targeted drug (cabozantinib) to two immunotherapy drugs (nivolumab and ipilimumab) can help shrink or stabilize the ca…
Matched conditions: METASTATIC NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC